高血压对莫亚莫亚病临床预后的影响:多中心倾向得分匹配分析

IF 16.4 1区 化学 Q1 CHEMISTRY, MULTIDISCIPLINARY Accounts of Chemical Research Pub Date : 2024-09-13 DOI:10.1007/s00701-024-06254-0
Basel Musmar, Joanna M. Roy, Hammam Abdalrazeq, Elias Atallah, Kareem El Naamani, Ching-Jen Chen, Roland Jabre, Hassan Saad, Jonathan A. Grossberg, Adam A. Dmytriw, Aman B. Patel, Mirhojjat Khorasanizadeh, Christopher S Ogilvy, Ajith J. Thomas, Andre Monteiro, Adnan Siddiqui, Gustavo M. Cortez, Ricardo A. Hanel, Guilherme Porto, Alejandro M. Spiotta, Anthony J. Piscopo, David M. Hasan, Mohammad Ghorbani, Joshua Weinberg, Shahid M. Nimjee, Kimon Bekelis, Mohamed M. Salem, Jan-Karl Burkhardt, Akli Zetchi, Charles Matouk, Brian M. Howard, Rosalind Lai, Rose Du, Rawad Abbas, Georgios S Sioutas, Abdelaziz Amllay, Alfredo Munoz, Nabeel A. Herial, Stavropoula I. Tjoumakaris, Michael Reid Gooch, Robert H. Rosenwasser, Pascal Jabbour
{"title":"高血压对莫亚莫亚病临床预后的影响:多中心倾向得分匹配分析","authors":"Basel Musmar,&nbsp;Joanna M. Roy,&nbsp;Hammam Abdalrazeq,&nbsp;Elias Atallah,&nbsp;Kareem El Naamani,&nbsp;Ching-Jen Chen,&nbsp;Roland Jabre,&nbsp;Hassan Saad,&nbsp;Jonathan A. Grossberg,&nbsp;Adam A. Dmytriw,&nbsp;Aman B. Patel,&nbsp;Mirhojjat Khorasanizadeh,&nbsp;Christopher S Ogilvy,&nbsp;Ajith J. Thomas,&nbsp;Andre Monteiro,&nbsp;Adnan Siddiqui,&nbsp;Gustavo M. Cortez,&nbsp;Ricardo A. Hanel,&nbsp;Guilherme Porto,&nbsp;Alejandro M. Spiotta,&nbsp;Anthony J. Piscopo,&nbsp;David M. Hasan,&nbsp;Mohammad Ghorbani,&nbsp;Joshua Weinberg,&nbsp;Shahid M. Nimjee,&nbsp;Kimon Bekelis,&nbsp;Mohamed M. Salem,&nbsp;Jan-Karl Burkhardt,&nbsp;Akli Zetchi,&nbsp;Charles Matouk,&nbsp;Brian M. Howard,&nbsp;Rosalind Lai,&nbsp;Rose Du,&nbsp;Rawad Abbas,&nbsp;Georgios S Sioutas,&nbsp;Abdelaziz Amllay,&nbsp;Alfredo Munoz,&nbsp;Nabeel A. Herial,&nbsp;Stavropoula I. Tjoumakaris,&nbsp;Michael Reid Gooch,&nbsp;Robert H. Rosenwasser,&nbsp;Pascal Jabbour","doi":"10.1007/s00701-024-06254-0","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive steno-occlusive changes in the internal carotid arteries, leading to an abnormal vascular network. Hypertension is prevalent among MMD patients, raising concerns about its impact on disease outcomes. This study aims to compare the clinical characteristics and outcomes of MMD patients with and without hypertension.</p><h3>Methods</h3><p>We conducted a multicenter, retrospective study involving 598 MMD patients who underwent surgical revascularization across 13 academic institutions in North America. Patients were categorized into hypertensive (<i>n=</i>292) and non-hypertensive (<i>n=</i>306) cohorts. Propensity score matching (PSM) was performed to adjust for baseline differences.</p><h3>Results</h3><p>The mean age was higher in the hypertension group (46 years vs. 36.8 years, <i>p &lt;</i> 0.001). Hypertensive patients had higher rates of diabetes mellitus (45.2% vs. 10.7%, <i>p &lt;</i> 0.001) and smoking (48.8% vs. 27.1%, <i>p &lt;</i> 0.001). Symptomatic stroke rates were higher in the hypertension group (16% vs. 7.1%; OR: 2.48; 95% CI: 1.39-4.40, <i>p =</i> 0.002) before matching. After PSM, there were no significant differences in symptomatic stroke rates (11.1% vs. 7.7%; OR: 1.5; CI: 0.64-3.47, <i>p =</i> 0.34), perioperative strokes (6.2% vs. 2.1%; OR 3.13; 95% CI: 0.83-11.82, <i>p =</i> 0.09), or good functional outcomes at discharge (93% vs. 92.3%; OR 1.1; 95% CI: 0.45-2.69, <i>p =</i> 0.82).</p><h3>Conclusion</h3><p>No significant differences in symptomatic stroke rates, perioperative strokes, or functional outcomes were observed between hypertensive and non-hypertensive Moyamoya patients. Appropriate management can lead to similar outcomes in both groups. Further prospective studies are required to validate these findings.</p></div>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00701-024-06254-0.pdf","citationCount":"0","resultStr":"{\"title\":\"The impact of hypertension on clinical outcomes in moyamoya disease: a multicenter, propensity score-matched analysis\",\"authors\":\"Basel Musmar,&nbsp;Joanna M. Roy,&nbsp;Hammam Abdalrazeq,&nbsp;Elias Atallah,&nbsp;Kareem El Naamani,&nbsp;Ching-Jen Chen,&nbsp;Roland Jabre,&nbsp;Hassan Saad,&nbsp;Jonathan A. Grossberg,&nbsp;Adam A. Dmytriw,&nbsp;Aman B. Patel,&nbsp;Mirhojjat Khorasanizadeh,&nbsp;Christopher S Ogilvy,&nbsp;Ajith J. Thomas,&nbsp;Andre Monteiro,&nbsp;Adnan Siddiqui,&nbsp;Gustavo M. Cortez,&nbsp;Ricardo A. Hanel,&nbsp;Guilherme Porto,&nbsp;Alejandro M. Spiotta,&nbsp;Anthony J. Piscopo,&nbsp;David M. Hasan,&nbsp;Mohammad Ghorbani,&nbsp;Joshua Weinberg,&nbsp;Shahid M. Nimjee,&nbsp;Kimon Bekelis,&nbsp;Mohamed M. Salem,&nbsp;Jan-Karl Burkhardt,&nbsp;Akli Zetchi,&nbsp;Charles Matouk,&nbsp;Brian M. Howard,&nbsp;Rosalind Lai,&nbsp;Rose Du,&nbsp;Rawad Abbas,&nbsp;Georgios S Sioutas,&nbsp;Abdelaziz Amllay,&nbsp;Alfredo Munoz,&nbsp;Nabeel A. Herial,&nbsp;Stavropoula I. Tjoumakaris,&nbsp;Michael Reid Gooch,&nbsp;Robert H. Rosenwasser,&nbsp;Pascal Jabbour\",\"doi\":\"10.1007/s00701-024-06254-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive steno-occlusive changes in the internal carotid arteries, leading to an abnormal vascular network. Hypertension is prevalent among MMD patients, raising concerns about its impact on disease outcomes. This study aims to compare the clinical characteristics and outcomes of MMD patients with and without hypertension.</p><h3>Methods</h3><p>We conducted a multicenter, retrospective study involving 598 MMD patients who underwent surgical revascularization across 13 academic institutions in North America. Patients were categorized into hypertensive (<i>n=</i>292) and non-hypertensive (<i>n=</i>306) cohorts. Propensity score matching (PSM) was performed to adjust for baseline differences.</p><h3>Results</h3><p>The mean age was higher in the hypertension group (46 years vs. 36.8 years, <i>p &lt;</i> 0.001). Hypertensive patients had higher rates of diabetes mellitus (45.2% vs. 10.7%, <i>p &lt;</i> 0.001) and smoking (48.8% vs. 27.1%, <i>p &lt;</i> 0.001). Symptomatic stroke rates were higher in the hypertension group (16% vs. 7.1%; OR: 2.48; 95% CI: 1.39-4.40, <i>p =</i> 0.002) before matching. After PSM, there were no significant differences in symptomatic stroke rates (11.1% vs. 7.7%; OR: 1.5; CI: 0.64-3.47, <i>p =</i> 0.34), perioperative strokes (6.2% vs. 2.1%; OR 3.13; 95% CI: 0.83-11.82, <i>p =</i> 0.09), or good functional outcomes at discharge (93% vs. 92.3%; OR 1.1; 95% CI: 0.45-2.69, <i>p =</i> 0.82).</p><h3>Conclusion</h3><p>No significant differences in symptomatic stroke rates, perioperative strokes, or functional outcomes were observed between hypertensive and non-hypertensive Moyamoya patients. Appropriate management can lead to similar outcomes in both groups. Further prospective studies are required to validate these findings.</p></div>\",\"PeriodicalId\":1,\"journal\":{\"name\":\"Accounts of Chemical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":16.4000,\"publicationDate\":\"2024-09-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://link.springer.com/content/pdf/10.1007/s00701-024-06254-0.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Accounts of Chemical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s00701-024-06254-0\",\"RegionNum\":1,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00701-024-06254-0","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

摘要

背景Moyamoya病(MMD)是一种罕见的脑血管疾病,其特征是颈内动脉发生进行性狭窄闭塞病变,导致血管网络异常。高血压在MMD患者中很普遍,这引起了人们对其对疾病预后影响的关注。本研究旨在比较有高血压和无高血压的 MMD 患者的临床特征和预后。方法我们进行了一项多中心回顾性研究,涉及北美 13 家学术机构中接受外科血管重建手术的 598 名 MMD 患者。患者被分为高血压组(292 人)和非高血压组(306 人)。结果高血压组患者的平均年龄更高(46岁对36.8岁,P< 0.001)。高血压患者的糖尿病患病率(45.2% 对 10.7%,p < 0.001)和吸烟率(48.8% 对 27.1%,p < 0.001)较高。匹配前,高血压组的症状性卒中发生率更高(16% vs. 7.1%;OR:2.48;95% CI:1.39-4.40,p = 0.002)。PSM 后,无症状中风率(11.1% vs. 7.7%;OR:1.5;CI:0.64-3.47,p = 0.34)、围手术期中风(6.2% vs. 2.1%;OR:3.13;95% CI:0.83-11.82,p = 0.09)或出院时良好功能预后(93% vs. 92.3%;OR:1.1;CI:0.64-3.47,p = 0.34)无显著差异。结论高血压和非高血压 Moyamoya 患者的症状性卒中发生率、围手术期卒中或功能预后无明显差异。适当的管理可使两组患者获得相似的预后。需要进一步的前瞻性研究来验证这些发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The impact of hypertension on clinical outcomes in moyamoya disease: a multicenter, propensity score-matched analysis

Background

Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive steno-occlusive changes in the internal carotid arteries, leading to an abnormal vascular network. Hypertension is prevalent among MMD patients, raising concerns about its impact on disease outcomes. This study aims to compare the clinical characteristics and outcomes of MMD patients with and without hypertension.

Methods

We conducted a multicenter, retrospective study involving 598 MMD patients who underwent surgical revascularization across 13 academic institutions in North America. Patients were categorized into hypertensive (n=292) and non-hypertensive (n=306) cohorts. Propensity score matching (PSM) was performed to adjust for baseline differences.

Results

The mean age was higher in the hypertension group (46 years vs. 36.8 years, p < 0.001). Hypertensive patients had higher rates of diabetes mellitus (45.2% vs. 10.7%, p < 0.001) and smoking (48.8% vs. 27.1%, p < 0.001). Symptomatic stroke rates were higher in the hypertension group (16% vs. 7.1%; OR: 2.48; 95% CI: 1.39-4.40, p = 0.002) before matching. After PSM, there were no significant differences in symptomatic stroke rates (11.1% vs. 7.7%; OR: 1.5; CI: 0.64-3.47, p = 0.34), perioperative strokes (6.2% vs. 2.1%; OR 3.13; 95% CI: 0.83-11.82, p = 0.09), or good functional outcomes at discharge (93% vs. 92.3%; OR 1.1; 95% CI: 0.45-2.69, p = 0.82).

Conclusion

No significant differences in symptomatic stroke rates, perioperative strokes, or functional outcomes were observed between hypertensive and non-hypertensive Moyamoya patients. Appropriate management can lead to similar outcomes in both groups. Further prospective studies are required to validate these findings.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Accounts of Chemical Research
Accounts of Chemical Research 化学-化学综合
CiteScore
31.40
自引率
1.10%
发文量
312
审稿时长
2 months
期刊介绍: Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.
期刊最新文献
Management of Cholesteatoma: Hearing Rehabilitation. Congenital Cholesteatoma. Evaluation of Cholesteatoma. Management of Cholesteatoma: Extension Beyond Middle Ear/Mastoid. Recidivism and Recurrence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1